US Federal Court Reopens PMI Patent Lawsuit and Revokes Attorney Fee

Business by Vapor Voice; Mandy Wong
Apr.19.2023
On April 17, the US Court of Appeals for the Federal Circuit (CAFC) overturned the district court's dismissal of a patent lawsuit filed by Healthier Choices Management (HCM) against Philip Morris (PMI).

 

 

On April 17, the US Court of Appeals for the Federal Circuit (CAFC) overturned a district court ruling: the District Court dismissed the patent lawsuit filed by Healthier Choices Management (HCM) against Philip Morris (PMI).

 

HCM Sues PMI for Infringement

 

Tobacco giant Philip Morris (PMI) is facing a patent infringement lawsuit from Florida-based e-cigarette company Healthier Choices Management (HCM). It is reported that HCM accused PMI of infringing its e-cigarette pipe patent, namely US Patent No. 10,561,170. After the prosecution, the district court ruled that PMI did not violate the patent and rejected HCM's application for amendment. Meanwhile, PMI received attorney's fees.

 

The main dispute between the two companies is whether one of PMI's products can trigger a combustion reaction. HCM claims that PMI's product does trigger a combustion reaction, while PMI claims the product is non-combustible. If the product involved combustion, PMI would be found to be infringing HCM's patent.

 

However, the District Court agreed with PMI, holding that the additional exhibits provided by HCM proved that PMI's products did not use combustion technology and therefore found no infringement, and the case was dismissed.

 

HCM Appeals to CAFC

 

HCM appealed against the judgment to the Court of Appeals for the Federal Circuit (CAFC). The CAFC upheld HCM's appeal, arguing that the district court had wrongly dismissed the plaintiff's complaint and denied its application for amendment. Accordingly, CAFC revoked PMI's award of attorney's fees and directed the case to be reopened.

 

HCM also requested that other judges hear the case, but CAFC rejected this request. The case will go back to Judge Timothy C. Batten of the US District Court for the Northern District of Georgia for a second instance.

 

Reference:

U.S. Appeals Court Revives Phillip Morris Patent Suit

 

Also read:

Argentina's Heat-not-burn Ban Causes PMI to Suspend Hundreds of Millions of dollars of Investment in IQOS

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
The U.S. Food and Drug Administration released a programmatic environmental assessment covering nicotine pouches and other oral nicotine products, concluding that their overall environmental impact is generally minimal.
Regulations
May.22
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Recent inspections and cargo disruption have led some logistics operators in the China-U.S. vape trade to see early signs of another U.S. border crackdown on illicit e-cigarettes. With late April to early May viewed as a key risk window, the market is watching closely. The bigger question is not only whether enforcement will tighten, but whether it can be sustained.
Special Report
Apr.09
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
The FDA issued warning letters to eight retailers selling unauthorized nicotine pouches and dissolvable tobacco products resembling candy, breath strips and cough drops. The action highlights rising scrutiny of packaging, youth appeal and accidental ingestion risks, as the agency clarifies enforcement priorities for unauthorized ENDS and nicotine pouch products while maintaining PMTA as the legal market pathway.
Special Report
May.21